Web7 Mar 2024 · Roflumilast is the generic ingredient in three branded drugs marketed by Arcutis, Astrazeneca, Breckenridge, Hetero Labs Ltd Iii, Micro Labs, MSN, Mylan, Prinston Inc, Strides Pharma, Torrent, and Zydus Pharms, and is included in eleven NDAs. There are nine patents protecting this compound and one Paragraph IV challenge. Web31 Aug 2024 · Weight loss was a common adverse reaction in Roflumilast Tablets clinical trials and was reported in 7.5% (331) of patients treated with Roflumilast Tablets 500 mcg …
Roflumilast List of Available Brand Names with Prices in …
WebCommon Brand Name(s): Daxas. Important: How To Use This Information. This is a summary and does NOT have all possible information about this product. This … Web7 Oct 2024 · While roflumilast as a molecule is already approved in oral tablet form (500mg) for chronic obstructive pulmonary disease under the brand name Daliresp (currently … mario vine png
Roflumilast: Uses, Interactions, Mechanism of Action - DrugBank
Web1 Nov 2024 · A new class of drug roflumilast, a selective phosphodiesterase4 (PDE4) inhibitor has been introduced in the market by USFDA in 2011 for patients with severe COPD associated with bronchitis and history of frequent exacerbations. This drug is typically used as an add-on treatment to existing one. Web14 Jan 2024 · Roflumilast - AstraZeneca. Alternative Names: APTA-2217; B 9302-107; BY 217; BYK 20869; Daliresp; Daxas; IN-ALR 01; Libertek. Latest Information Update: 28 Jul … WebRoflumilast is a specific phosphodiesterase type (4PDE4) inhibitor indicated for use as a treatment to reduce the risk of COPD exacerbations in patients with severe COPD associated with chronic bronchitis and a history of exacerbations. ... Brand Name English 3-CYCLOPROPYLMETHOXY-N-(3,5-DICHLOROPYRIDIN-4-YL)-4 … dani accessories handbag